中東およびアフリカのオピオイド市場は、2022年に2億4,922万米ドルと評価され、2030年までに2億9,979万米ドルに達すると予想されています。2022年から2030年までに2.3%のCAGRが記録されると推定されています。
心血管疾患、がん、筋骨格系疾患、神経血管疾患などの慢性疾患は、免疫力を低下させることで人の健康に重大な影響を与えます。さらに、これらの症状に苦しむ多くの患者は慢性的な痛みを経験しています。上記の病気は、成人および高齢者集団に最もよく見られます。それにもかかわらず、これらの病気の症例は子供の間でも顕著に増加しています。慢性的な痛みは、スポーツ選手、アスリート、過去に怪我を負った人にもよく見られます。NCBI（国立バイオテクノロジー情報センター）で発表された研究によると、世界中で成人の20%が痛みに苦しんでおり、毎年10%が新たに慢性疼痛と診断されています。痛みは、性別、人種/民族、収入、年齢、地理に関係なく、すべての人々に影響を及ぼしますが、世界中に平等に分布しているわけではありません。ヒドロコドン、オキシコドン、モルヒネなどの処方オピオイドは、怪我、手術、がんや関節炎などの健康状態によって引き起こされる痛みの治療に使用される強力な鎮痛薬です。
議会調査局（Congressional Research Service）によると、アメリカ人はより包括的な疼痛治療を犠牲にして、より多くのオピオイドを摂取する可能性があります。オピオイド処方の増加は、代替疼痛治療よりもオピオイドを奨励する保険償還プログラム、より効率的なケアを奨励するコスト構造、患者の満足度と効果的な疼痛管理を組み合わせた評価に起因すると考えられます。したがって、疼痛管理におけるオピオイドの利点により、慢性疾患患者の間で需要が高まっています。
中東およびアフリカのオピオイド市場は、南アフリカ、UAE、サウジアラビア、およびその他の中東およびアフリカに分割されています。中東およびアフリカでは、オピオイドは鎮痛、緩和ケア、オピオイド中毒の解消に使用されています。オピオイド使用障害の標準治療には、メタドン、ブプレノルフィン、ナルトレキソンなどの薬剤を使用した治療が含まれます。これらのオピオイド使用障害（MOUD）治療薬は、オピオイドの過剰摂取による死亡を減らします。2020年、MOUDはレバノン、モロッコ、イラン、パレスチナ自治区でのみオピオイド使用障害の治療法として利用可能でした。地域のいくつかの国では経済と医療の発展が進んでいるにもかかわらず、中東およびアフリカではオピオイド消費の増加は限定的です。
製品に基づいて、中東およびアフリカのオピオイド市場は、即時放出型短時間作用型オピオイドと徐放性長時間作用型オピオイドに分類されます。即時放出型短時間作用型オピオイドセグメントは、2022年に大きな市場シェアを保持しました。即時放出型短時間作用型オピオイドは、オキシコドン、ヒドロコドン、トラマドール、コデイン、プロポキシフェンなどにさらにサブセグメント化されています。徐放性長時間作用性オピオイドは、オキシコドン、フェンタニル、モルヒネ、メサドンなどにさらにサブセグメント化されます。
用途に関して、中東およびアフリカのオピオイド市場は、疼痛管理、麻酔、下痢抑制、咳止め、脱依存症などに分類されます。疼痛管理セグメントは、2022年に最大の市場シェアを保持しました。
流通チャネル別にみると、中東およびアフリカのオピオイド市場は病院薬局と小売薬局に二分されます。2022年には病院薬局部門がより大きな市場シェアを獲得しました。
国ごとに、中東およびアフリカのオピオイド市場は、サウジアラビア、南アフリカ、UAE、およびその他の中東およびアフリカに分割されています。2022年に、南アフリカが中東およびアフリカのオピオイド市場シェアを独占しました。
Neuraxpharm Pharmaceuticals SL社、Endo International plc社、Hikma Pharmaceuticals Plc社、Mallinckrodt Plc社、Rusan Pharma Ltd社、およびTeva Pharmaceutical Industries Ltd社は、中東およびアフリカのオピオイド市場で事業を展開する大手企業です。
目次
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Middle East & Africa Analysis
5.1 Middle East & Africa Opioids Market Overview
5.2 Middle East & Africa Opioids Market Revenue (US$ Million), 2020-2030
5.3 Middle East & Africa Opioids Market Forecast Analysis
6. Middle East & Africa Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Middle East & Africa Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Opioids Market - Country Analysis
10.1 Middle East & Africa
10.1.1 Middle East & Africa: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.2.2 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.2.4 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.2.5 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.2.6 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
10.1.1.3 South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 South Africa: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.3.2 South Africa: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 South Africa: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.3.4 South Africa: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.3.5 South Africa: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.3.6 South Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
10.1.1.4 United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.4.2 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.4.4 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.4.5 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.4.6 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
10.1.1.5 Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.5.6 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hikma Pharmaceuticals Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Opioids Market Segmentation
Table 2. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 13. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration
Table 15. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 19. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration
Table 21. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 25. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 31. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration
Table 33. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Recent Organic Growth Strategies in Opioids Market
Table 35. Recent Inorganic Growth Strategies in the Opioids Market
Table 36. Glossary of Terms, Opioids Market
LIST OF FIGURES
Figure 1. Middle East & Africa Opioids Market Segmentation, by Country
Figure 2. Middle East & Africa Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Middle East & Africa Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Middle East & Africa Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Middle East & Africa Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Middle East & Africa Opioids Market, by Key Countries, Revenue (2022) (US$ Million)
Figure 23. Middle East & Africa: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in Opioids Market
